Skip to content

Welcome to Discover Pharma! Today is : October 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Neurodegeneration

  • Central Nervous System,Drug Discovery & Development,Research & Development,Therapeutic Areas

    $3M funding targets tau-driven neurodegenerative diseases

    A $3m research programme will fund four projects investigating the [...]

    September 14, 2026
  • Central Nervous System,Genomics and sequencing,Research & Development,Therapeutic Areas

    Alamar expands Alzheimer’s proteomics partnership with 86,000 more samples

    Alamar Biosciences is expanding a partnership with the Alzheimer’s Disease [...]

    August 12, 2026
  • Central Nervous System,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    ABLi reports biomarker changes supporting disease-modifying potential of Parkinson’s drug

    ABLi Therapeutics has reported coordinated changes across 11 biomarkers linked [...]

    August 4, 2026
  • Clinical & Regulatory,Medical devices,Research & Development,Therapeutic Areas

    Alamar launches blood-based eMTBR-Tau assay for Alzheimer’s disease research

    Alamar Biosciences has launched what it describes as the first [...]

    July 8, 2026
  • Pharmaceuticals and therapeutics,Therapeutic Areas

    Scenic Biotech joins Michael J. Fox Foundation Parkinson’s research programme

    Scenic Biotech has joined the Michael J. Fox Foundation’s LRRK2 [...]

    June 11, 2026
  • Central Nervous System,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Porosome reconstitution therapy reverses Alzheimer’s pathology in human brain organoids

    Porosome Therapeutics has reported preclinical results showing that restoring porosome [...]

    May 5, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics

    Galimedix completes phase 1 trial of oral Alzheimer’s drug GAL-101

    Galimedix Therapeutics has completed a phase 1 study of its [...]

    May 5, 2026
  • Clinical & Regulatory,Therapeutic Areas

    From symptoms to biology: Neurodegeneration in the paraventricular thalamus in bipolar disorder

    Accumulation of neurodegenerative proteins could be key to understanding bipolar [...]

    May 5, 2026
  • Advanced Therapies,Central Nervous System,Drug Discovery & Development

    $2.5M awarded to fuel breakthrough research into tau-driven neurodegenerative diseases

    The Rainwater Charitable Foundation, Aging Mind Foundation, Alzheimer’s Association, and [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    AltPep data highlights potential of intranasal peptide for early-stage Alzheimer’s

    AltPep Corporation has presented new preclinical findings at the Alzheimer’s [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • MaaT Pharma to advance Phase 3 trial after EMA rejects MaaT013 application
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Saudi Arabia announces biotech deals and research partnerships worth SAR 5.5BN
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Genomics and sequencing, Manufacturing & Supply Chain, Research & Development
  • Big Picture Bio launches with £2.2M to design cancer drug combinations
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top